Moving the goalposts: a covid-19 vaccine poses risk to patent-holders

Covid-19 has put the world on hold; most experts say the prospect of lifting lockdown measures relies heavily on finding an effective vaccine to stop the virus spreading. Several governments look set to introduce controversial compulsory licensing laws for any breakthrough vaccine to become publicly available, but legal teams in Latin America have voiced concerns about how this will impact IP rights in the region.